Oral GLP-1 Weight-Loss Pills Break Through, Shifting the Injectable Era
STAT News explains why turning GLP-1 weight‑loss drugs into pills has been so challenging, highlighting Novo Nordisk’s Wegovy oral version and Lilly’s orforglipron, and what the shift could mean for pricing and accessibility as these pills head toward approval.